Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-15 4:31 pm Sale | 2024-10-10 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,468,099 6.200% | -782,979 (-24.08%) | Filing History |
| 2024-10-10 4:30 pm Purchase | 2024-10-08 | 13D | OnKure Therapeutics, Inc. OKUR | Carlyle Group Inc. CG | 273,045 2.200% | 273,045 (New Position) | Filing History |
| 2024-10-10 4:30 pm Sale | 2024-10-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 3,251,078 8.100% | -745,287 (-18.65%) | Filing History |
| 2024-09-10 6:30 pm Purchase | 2024-09-06 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 3,996,365 9.990% | 1,102,750 (+38.11%) | Filing History |
| 2024-08-05 4:30 pm Sale | 2024-08-02 | 13D | QuidelOrtho Corporation QDEL | Carlyle Group Inc. CG | 8,724,346 13.000% | -719,869 (-7.62%) | Filing History |
| 2024-07-30 4:30 pm Sale | 2024-07-26 | 13D | QuidelOrtho Corporation QDEL | Carlyle Group Inc. CG | 9,444,215 14.100% | -883,557 (-8.56%) | Filing History |
| 2024-07-24 4:30 pm Sale | 2024-07-23 | 13D | QuidelOrtho Corporation QDEL | Carlyle Group Inc. CG | 10,327,772 15.400% | -717,230 (-6.49%) | Filing History |
| 2024-07-15 4:30 pm Sale | 2024-07-11 | 13D | QuidelOrtho Corporation QDEL | Carlyle Group Inc. CG | 11,045,002 16.500% | -721,020 (-6.13%) | Filing History |
| 2024-07-11 5:02 pm Purchase | 2024-07-01 | 13G | SunPower Corporation SPWR | Carlyle Group Inc. CG | 10,888,864 17.700% | 8,142,985 (+296.55%) | Filing History |
| 2024-07-08 6:15 pm Purchase | 2024-06-28 | 13D | Cano Health, Inc. CANO | Carlyle Group Inc. CG | 2,801,906 6.700% | 2,801,906 (New Position) | Filing History |
| 2024-06-25 5:00 pm Purchase | 2024-06-24 | 13D | QuidelOrtho Corporation QDEL | Carlyle Group Inc. CG | 11,766,022 17.600% | 11,766,022 (New Position) | Filing History |
| 2024-05-14 4:30 pm Sale | 2024-05-12 | 13D | QuidelOrtho Corporation QDEL | Carlyle Group Inc. CG | 0 0.000% | -12,460,183 (Position Closed) | Filing History |
| 2024-05-13 4:05 pm Sale | 2024-05-09 | 13D | eFFECTOR Therapeutics, Inc. EFTR | Carlyle Group Inc. CG | 193,195 4.100% | -1 (-0.00%) | Filing History |
| 2024-03-29 4:30 pm Purchase | 2024-03-25 | 13G | Q32 Bio Inc. QTTB | Carlyle Group Inc. CG | 1,102,741 9.200% | 1,102,741 (New Position) | Filing History |
| 2024-03-05 4:10 pm Sale | 2024-03-01 | 13D | The Carlyle Group Inc. CG | Carlyle Group Management L.L.C. | 140,827,506 39.000% | -11,303,498 (-7.43%) | Filing History |
| 2024-02-13 4:55 pm Sale | 2023-12-29 | 13G | The Carlyle Group Inc. CG | VANGUARD GROUP INC | 24,876,188 6.890% | -76,681 (-0.31%) | Filing History |
| 2024-02-12 6:00 pm Purchase | 2024-02-08 | 13D | Jasper Therapeutics, Inc. JSPR | Carlyle Group Inc. CG | 1,066,189 7.100% | 190,000 (+21.68%) | Filing History |
| 2024-02-12 5:46 pm Sale | 2023-12-31 | 13G | ZoomInfo Technologies Inc. GTM | Carlyle Group Inc. CG | 35,244,474 9.000% | -1,417,995 (-3.87%) | Filing History |
| 2024-02-12 5:45 pm Sale | 2023-12-31 | 13G | MKS Inc. MKSI | Carlyle Group Inc. CG | 0 0.000% | -8,482,732 (Position Closed) | Filing History |
| 2024-02-12 4:36 pm Purchase | 2023-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 6.100% | 561,702 (+19.14%) | Filing History |